Morgan Group Holding Co. (MGHL)
OTC PINK OTC PINK Primary 
Morgan Stanley Q3 Earnings Beat on Deal-Making Boom, Solid Trading
MS' Q3 earnings jump 49% on booming deal-making activity and strong trading, pushing shares up almost 4.5% pre-market.
Kinder Morgan Falls After Earnings 55% Of The Time - Another Drop Ahead?
Kinder Morgan (NYSE: KMI) is a prominent energy infrastructure firm that specializes in the transportation and storage of natural gas, oil, CO₂, and bulk materials. The company is scheduled to announce its fiscal third-quarter earnings on Wednesday, October 15, 2025.
Goldman Sachs And Morgan Stanley Earnings Preview: Investment Banking Revenues Will Drive Quarterly Results
The big tailwind for Goldman Sachs (GS) and Morgan Stanley (MS) is expected to be the resurgence in M&A in '25, particularly around AI and all the deals which have seemed to pop up on a weekly basis the last 3 months. Analyst consensus for GS coming into Tuesday morning's release is for $11 billion (even) in net revenue and $10.99 in EPS, for expected y-o-y growth of 11% and 31%, respectively. Morgan Stanley consensus for Wednesday morning's October 15th, 2025, expected earnings release is $16.7 billion in revenue and $2.10 in EPS, for expected y-o-y growth of 9% and 12%, respectively.
Should You Consider Buying Morgan Stanley Stock Before Earnings?
Morgan Stanley (NYSE:MS) is scheduled to announce its earnings on Wednesday, October 15, 2025. The earnings forecast stands at $2.07, up from $1.88 during the same quarter last year, while revenue is expected to increase by approximately 6.5% to reach $16.4 billion.
Robust Trading, IB Fee Growth to Aid Morgan Stanley's Q3 Earnings
MS's Q3 results are set to shine, fueled by robust trading activity and rising investment banking fees.
Morgan Stanley drops restrictions on which wealth clients can own crypto funds
Morgan Stanley on Friday told its financial advisors that the firm was broadening access to crypto investments to all clients and allowing such investments in any type of account, including retirement accounts, CNBC has learned. Starting Oct. 15, advisors will be able to pitch crypto funds to any client.
JP Morgan backs Lion Finance as a quiet emerging markets success
Lion Finance Group PLC (LSE:BGEO) may not yet roar on UK screens, but JP Morgan thinks it deserves a louder following. The US bank has begun coverage with an “overweight” rating and a December 2026 price target of £92, calling it a “structural emerging markets growth story” and an “Apex compounder”.
Micron's stock has doubled this year. Why Morgan Stanley is finally upgrading it.
“Better late than never,” a Morgan Stanley analyst says as he cheers booming memory prices that could drive “substantially higher earnings power” for Micron.
Morgan Stanley Direct Lending: Buy The Dip Opportunity
MSDL has seen its stock price decline ~20% YTD, creating a significant valuation gap versus peer BXSL. Morgan Stanley Direct Lending now trades at ~0.8x NAV compared to BXSL's 1.0x, making the current discount and income potential attractive for investors. Despite concerns over dividend coverage and declining net investment income, I upgrade MSDL to a 'strong buy' due to upside from multiple appreciation.
Morgan Stanley says buy into weakness in Flutter and DraftKings after Kalshi enters parlays market
The stock-price sell-off in FanDuel's parent company and DraftKings was too severe, an analyst is arguing on Wednesday.
Here's Why Morgan Stanley Analysts Downgraded Novo Nordisk's Stock
An analyst's concerns about demand for Novo Nordisk's blockbuster weight-loss drugs is weighing on the drugmaker's shares to start the week.
Morgan Stanley expects Novo Nordisk Alzheimer trial to fail as it slashes rating
Morgan Stanley analysts say a trial to test whether Novo Nordisk's blockbuster weight-loss drug also will work against Alzheimer's is likely to fail, as it set the most pessimistic target price forecast of any Wall Street bank on the Danish drugmaker.
